Hangzhou AllTest Biotech Co., Ltd. · Class I · Cleared Apr 30, 2026
| K-number | K260342 |
| Device name | AllTest Strep A Rapid Test |
| Applicant | Hangzhou AllTest Biotech Co., Ltd. |
| Product code | GTY |
| Device class | Class I |
| Decision date | Apr 30, 2026 |
| Decision | Substantially Equivalent |
| Regulation | 866.3740 |
The AllTest Strep A Rapid Test is a rapid chromatographic immunoassay for qualitative detection of Streptococcus pyogenes (Group A Streptococcus) antigens in throat swab specimens from patients with signs and symptoms of pharyngitis. It aids in diagnosis of Group A Streptococcus infection, though negative results must be confirmed by bacterial culture.
The device uses a cassette-format lateral flow immunoassay with rabbit anti-Strep A antibodies, compared to the predicate's strip format with goat polyclonal anti-Strep A antibodies. It achieves 5-minute result reading time (versus 10 minutes for predicate), clinical sensitivity of 95.0% (95% CI: 89.6%–97.7%), and clinical specificity of 99.0% (95% CI: 97.5%–99.6%). Analytical sensitivity is 1.0×10⁴ CFU/swab.
Not stated in this summary.
The AllTest device is substantially equivalent to the predicate Wondfo One Step Strep A Swab Test (K133343) because both use immunochromatographic assays with rabbit anti-Strep A antibodies to detect antigen in throat swab specimens for the same indication (prescription use diagnosis of Group A Streptococcus). The device demonstrates acceptable analytical performance (precision, limit of detection, absence of cross-reactivity with 47 respiratory pathogens, no interference from common throat medications), comparable clinical performance across age groups, and non-inferior sensitivity and specificity to the predicate.
View the full FDA submission: accessdata.fda.gov